This consortium, which includes U.S. healthcare executive Andrew Cavenagh, aims to acquire a controlling stake in the club. Former chairman Dave King, holding a 12.96% share, has been instrumental in these negotiations and is prepared to sell his shares, viewing this potential takeover as a fitting legacy for the club.
In parallel, Rangers have unveiled ambitious plans to enhance their infrastructure. The club has initiated a feasibility study to assess the introduction of a safe standing area at Ibrox Stadium. This initiative is part of a broader multi-million-pound redevelopment strategy aimed at upgrading disabled facilities and potentially expanding the stadium’s capacity. Proposed developments include installing new platforms in the Copland and Broomloan Stands, which could increase the overall capacity to approximately 51,500 seats.
Additionally, Rangers are exploring further expansion options to accommodate the growing demand from supporters. Three primary proposals are under consideration: adding 1,300 seats to each corner of the stadium where the current big screens are located, removing the screens entirely to add between 3,000 to 4,000 seats, or lowering the pitch to introduce 4,500 additional seats. These projects are estimated to cost between £3 million to £25 million, depending on the chosen option.
These prospective investments and developments signify a pivotal moment for Rangers, aiming to bolster the club’s financial standing, enhance fan experience, and strengthen its competitive position both domestically and in European competitions.
Be the first to comment